Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2011:2011:497841.
doi: 10.1155/2011/497841. Epub 2011 Feb 16.

Animal models of cardiovascular diseases

Affiliations
Review

Animal models of cardiovascular diseases

Carlos Zaragoza et al. J Biomed Biotechnol. 2011.

Abstract

Cardiovascular diseases are the first leading cause of death and morbidity in developed countries. The use of animal models have contributed to increase our knowledge, providing new approaches focused to improve the diagnostic and the treatment of these pathologies. Several models have been developed to address cardiovascular complications, including atherothrombotic and cardiac diseases, and the same pathology have been successfully recreated in different species, including small and big animal models of disease. However, genetic and environmental factors play a significant role in cardiovascular pathophysiology, making difficult to match a particular disease, with a single experimental model. Therefore, no exclusive method perfectly recreates the human complication, and depending on the model, additional considerations of cost, infrastructure, and the requirement for specialized personnel, should also have in mind. Considering all these facts, and depending on the budgets available, models should be selected that best reproduce the disease being investigated. Here we will describe models of atherothrombotic diseases, including expanding and occlusive animal models, as well as models of heart failure. Given the wide range of models available, today it is possible to devise the best strategy, which may help us to find more efficient and reliable solutions against human cardiovascular diseases.

PubMed Disclaimer

References

    1. Getz GS, Reardon CA. Diet and murine atherosclerosis. Arteriosclerosis, Thrombosis, and Vascular Biology. 2006;26(2):242–249. - PubMed
    1. Meir KS, Leitersdorf E. Atherosclerosis in the apolipoprotein E-deficient mouse: a decade of progress. Arteriosclerosis, Thrombosis, and Vascular Biology. 2004;24(6):1006–1014. - PubMed
    1. Whitman SC. A practical approach to using mice in atherosclerosis research. The Clinical Biochemist Reviews. 2004;25:81–93. - PMC - PubMed
    1. Zadelaar S, Kleemann R, Verschuren L, et al. Mouse models for atherosclerosis and pharmaceutical modifiers. Arteriosclerosis, Thrombosis, and Vascular Biology. 2007;27(8):1706–1721. - PubMed
    1. Ishibashi S, Brown MS, Goldstein JL, Gerard RD, Hammer RE, Herz J. Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery. Journal of Clinical Investigation. 1993;92(2):883–893. - PMC - PubMed

Publication types

MeSH terms